A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease

Respiratory Research

Volumn 8, Issue , 2007, Pages

  Hopkinson, Nicholas S ^a   Tennant, Rachel C ^a   Dayer, Mark J ^a   Swallow, Elisabeth B ^a   Hansel, Trevor T ^a   Moxham, John ^b   Polkey, Michael I ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

AGED; ARTICLE; BODY COMPOSITION; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; LUNG FUNCTION TEST; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; QUALITY OF LIFE; REGRESSION ANALYSIS; SKELETAL MUSCLE; SMOKING CESSATION; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; AGED; BODY COMPOSITION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; REGRESSION ANALYSIS; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUSCLES; SMOKING CESSATION; WEIGHT LOSS;

EID: 34247857681     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-8-25     Document Type: Article

References (46)

1. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999, 159(4 Pt 2):S1-40.
2. Schols AMWJ, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005, 82(1):53-59.
3. Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000, 94(9):859-867. 10.1053/rmed.2000.0829, 11001077.
4. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002, 20(3):539-544. 10.1183/09031936.02.00532002, 12358326.
5. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160(6):1856-1861.
6. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157(6 Pt 1):1791-1797.
7. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995, 152(6):2021-2031.
8. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F. Peripheral Muscle Weakness in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 1998, 158(2):629-634.
9. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996, 153(3):976-980.
10. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F. Midthigh Muscle Cross-Sectional Area Is a Better Predictor of Mortality than Body Mass Index in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2002, 166(6):809-813. 10.1164/rccm.2107031, 12231489.
11. Swallow EB, Reyes D, Hopkinson NS, Man WDC, Porcher R, Cetti EJ, Moore AJ, Moxham J, Polkey MI. Quadriceps strength predicts mortality in patients with moderate to severe Chronic Obstructive Pulmonary Disease. Thorax 2007, 62:115-120. 10.1136/thx.2006.062026, 17090575.
12. Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994, 150(1):11-16.
13. Hopkinson NS, Nickol AH, Payne J, Hawe E, Man WD, Moxham J, Montgomery H, Polkey MI. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170(4):395-399. 10.1164/rccm.200304-578OC, 15117739.
14. Hopkinson NS, Eleftheriou KI, Payne J, Nickol AH, Hawe E, Moxham J, Montgomery H, Polkey MI. +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2006, 83(4):912-917.
15. Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, Bouillon R, Decramer M. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003, 58(9):752-756. 10.1136/thorax.58.9.752, 12947130.
16. Saudny-Unterberger H, Martin JG, Gray-Donald K. Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997, 156(3 Pt 1):794-799.
17. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001, 163(5):1256-1276.
18. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. The American review of respiratory disease 1992, 145(6):1321-1327.
19. Hopkinson NS, Toma TP, Hansell DM, Goldstraw P, Moxham J, Geddes DM, Polkey MI. Effect of Bronchoscopic Lung Volume Reduction on Dynamic Hyperinflation and Exercise in Emphysema. Am J Respir Crit Care Med 2005, 171(5):453-460. 10.1164/rccm.200407-961OC, 15579725.
20. Steiner MC, Barton RL, Singh SJ, Morgan MD. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002, 19(4):626-631. 10.1183/09031936.02.00279602, 11998990.
21. Edwards RHT, Young A, Hosking GP, Jones DA. Human skeletal muscle function: description of tests and normal values. Clin Sci Mol Med 1977, 52:283-290.
22. Uldry C, Janssens JP, de Muralt B, Fitting JW. Sniff nasal inspiratory pressure in patients with chronic obstructive pulmonary disease. Eur Respir J 1997, 10:1292-1296. 10.1183/09031936.97.10061292, 9192931.
23. Wilson SH, Cooke NT, Edwards RHT, Spiro SG. Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax 1984, 39:535-538.
24. Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, Calverley PMA, Chavannes N, Dillard T, Fahy B, Fein A, Heffner J, Lareau S, Meek P, Martinez F, McNicholas W, Muris J, Austegard E, Pauwels R, Rennard S, Rossi A, Siafakas N, Tiep B, Vestbo J, Wouters E, ZuWallack R. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23(6):932-946.
25. Frontera WR, Hughes VA, Fielding RA, Fiatarone MA, Evans WJ, Roubenoff R. Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol 2000, 88(4):1321-1326.
26. Ferrucci L, Penninx BWJH, Volpato S, Harris TB, Bandeen-Roche K, Balfour J, Leveille SG, Fried LP, Md JMG. Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin-6 Serum Levels. Journal of the American Geriatrics Society 2002, 50(12):1947-1954. 10.1046/j.1532-5415.2002.50605.x, 12473005.
27. Young A. Ageing and physiological functions. Philos Trans R Soc Lond B Biol Sci 1997, 352(1363):1837-1843. 1692134, 9460068, 10.1098/rstb.1997.0169.
28. Laukkanen PIA, Heikkinen E, Kauppinen M. Muscle Strength and Mobility as Predictors of Survival in 75-84 - Year - old People. Age Ageing 1995, 24:468-473. 10.1093/ageing/24.6.468, 8588534.
29. Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, Tylavsky FA, Rubin SM, Harris TB. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 2006, 61(1):72-77.
30. Schols AM, Dingemans AM, Soeters PB, Wouters EF. Within-day variation of bioelectrical resistance measurements in patients with chronic obstructive pulmonary disease. Clin Nutr 1990, 9(5):266-271. 10.1016/0261-5614(90)90035-Q, 16837369.
31. Morton JP, Atkinson G, MacLaren DP, Cable NT, Gilbert G, Broome C, McArdle A, Drust B. Reliability of maximal muscle force and voluntary activation as markers of exercise-induced muscle damage. Eur J Appl Physiol 2005, 94(5-6):541-548. 10.1007/s00421-005-1373-9, 15928932.
32. Hopkinson NS, Man WD, Dayer MJ, Ross ET, Nickol AH, Hart N, Moxham J, Polkey MI. Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur Respir J 2004, 24(1):137-142. 10.1183/09031936.04.00139003, 15293616.
33. Clark CJ, Cochrane L, Mackay E. Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD. Eur Respir J 1996, 9(12):2590-2596. 10.1183/09031936.96.09122590, 8980974.
34. Schonhofer B, Zimmermann C, Abramek P, Suchi S, Kohler D, Polkey MI. Non-invasive mechanical ventilation improves walking distance but not quadriceps strength in chronic respiratory failure. Respiratory Medicine 2003, 97(7):818-824. 10.1016/S0954-6111(03)00037-4, 12854632.
35. Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 1995, 152(4 Pt 1):1268-1274.
36. Burdet L, de Muralt B, Schutz Y, Pichard C, Fitting JW. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med 1997, 156(6):1800-1806.
37. Ferreira IM, Verreschi IT, Nery LE, Goldstein RS, Zamel N, Brooks D, Jardim JR. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 1998, 114(1):19-28.
38. Eid AA, Ionescu AA, Nixon LS, Lewis-Jenkins V, Matthews SB, Griffiths TL, Shale DJ. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164(8):1414-1418.
39. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993, 147(5):1151-1156.
40. Cohen RI, Marzouk K, Berkoski P, O'Donnell CP, Polotsky VY, Scharf SM. Body Composition and Resting Energy Expenditure in Clinically Stable, Non-Weight-Losing Patients With Severe Emphysema. Chest 2003, 124(4):1365-1372. 10.1378/chest.124.4.1365, 14555567.
41. Engelen MP, Schols AM, Baken WC, Wesseling GJ, Wouters EF. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 1994, 7(10):1793-1797. 10.1183/09031936.94.07101793, 7828687.
42. Creutzberg EC, Wouters EFM, Mostert R, Weling-Scheepers CAPM, Schols AMWJ. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 2003, 19(2):120-127. 10.1016/S0899-9007(02)00841-9, 12591542.
43. Groenewegen KH, Schols AM, Wouters EF. Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD. Chest 2003, 124(2):459-467. 10.1378/chest.124.2.459, 12907529.
44. Schols AM, Wesseling G, Kester AD, de Vries G, Mostert R, Slangen J, Wouters EF. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. Eur Respir J 2001, 17(3):337-342. 10.1183/09031936.01.17303370, 11405508.
45. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977, 1(6077):1645-1648. 1607732, 871704.
46. Bermudez EA, Rifai N, Buring JE, Manson JAE, Ridker PM. Relation between markers of systemic vascular inflammation and smoking in women. The American Journal of Cardiology 2002, 89(9):1117-1119. 10.1016/S0002-9149(02)02284-1, 11988205.